Kyowa Kirin Completes Acquisition Of Orchard Therapeutics
Portfolio Pulse from Benzinga Newsdesk
Kyowa Kirin has successfully completed the acquisition of Orchard Therapeutics, making it a wholly-owned subsidiary as of January 24, 2024, through a Scheme of Arrangement under the UK Companies Act 2006.
January 24, 2024 | 10:34 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Orchard Therapeutics has been acquired by Kyowa Kirin and is now a wholly-owned subsidiary of the company.
As Orchard Therapeutics has been acquired and is no longer an independent company, its shares will likely be delisted from the stock exchange. This typically results in the stock no longer being publicly traded, which would negatively impact its liquidity and availability to investors.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100